Eric M. Ostertag, MD, PhD, chief executive officer, Poseida Therapeutics, Inc., discusses an emerging CAR T stem cell memory product for patients with relapsed/refractory multiple myeloma.
Eric M. Ostertag, MD, PhD
Advertisement
Articles by Eric M. Ostertag, MD, PhD
Advertisement
Latest Updated Articles
Dr. Ostertag on Emerging CAR T Product for MyelomaPublished: August 29th 2018 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
M. Peter Marinkovich, MD, on Integrating Gene Therapy into Clinical Practice for Dermatologists
2
Quarter Century Update: How can Partnerships Between Academia, Biotech, and Pharma be Better Structured?
3
Quarter Century Update: Platform Approaches and Industry Investment
4
